|
|
(One intermediate revision not shown.) |
Line 1: |
Line 1: |
| | | |
| ==CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-11== | | ==CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-11== |
- | <StructureSection load='5i16' size='340' side='right' caption='[[5i16]], [[Resolution|resolution]] 1.90Å' scene=''> | + | <StructureSection load='5i16' size='340' side='right'caption='[[5i16]], [[Resolution|resolution]] 1.90Å' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[5i16]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5I16 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5I16 FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[5i16]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5I16 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5I16 FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MES:2-(N-MORPHOLINO)-ETHANESULFONIC+ACID'>MES</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.9Å</td></tr> |
- | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=PCA:PYROGLUTAMIC+ACID'>PCA</scene></td></tr> | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MES:2-(N-MORPHOLINO)-ETHANESULFONIC+ACID'>MES</scene>, <scene name='pdbligand=PCA:PYROGLUTAMIC+ACID'>PCA</scene></td></tr> |
- | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5i15|5i15]], [[5i17|5i17]], [[5i18|5i18]], [[5i19|5i19]], [[5i1a|5i1a]], [[5i1c|5i1c]], [[5i1d|5i1d]], [[5i1e|5i1e]], [[5i1g|5i1g]], [[5i1h|5i1h]], [[5i1i|5i1i]], [[5i1j|5i1j]], [[5i1k|5i1k]], [[5i1l|5i1l]], [[4kmt|4kmt]]</td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5i16 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5i16 OCA], [https://pdbe.org/5i16 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5i16 RCSB], [https://www.ebi.ac.uk/pdbsum/5i16 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5i16 ProSAT]</span></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5i16 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5i16 OCA], [http://pdbe.org/5i16 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5i16 RCSB], [http://www.ebi.ac.uk/pdbsum/5i16 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5i16 ProSAT]</span></td></tr> | + | |
| </table> | | </table> |
| <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
Line 22: |
Line 21: |
| __TOC__ | | __TOC__ |
| </StructureSection> | | </StructureSection> |
- | [[Category: Gilliland, G]] | + | [[Category: Homo sapiens]] |
- | [[Category: Luo, J]] | + | [[Category: Large Structures]] |
- | [[Category: Malia, T]] | + | [[Category: Gilliland G]] |
- | [[Category: Obmolova, G]] | + | [[Category: Luo J]] |
- | [[Category: Teplyakov, A]] | + | [[Category: Malia T]] |
- | [[Category: Immune system]] | + | [[Category: Obmolova G]] |
- | [[Category: Monoclonal antibody]] | + | [[Category: Teplyakov A]] |
| Structural highlights
Publication Abstract from PubMed
To support antibody therapeutic development, the crystal structures of a set of 16 germline variants composed of 4 different kappa light chains paired with 4 different heavy chains have been determined. All four heavy chains of the antigen-binding fragments (Fabs) have the same complementarity-determining region (CDR) H3 that was reported in an earlier Fab structure. The structure analyses include comparisons of the overall structures, canonical structures of the CDRs and the VH:VL packing interactions. The CDR conformations for the most part are tightly clustered, especially for the ones with shorter lengths. The longer CDRs with tandem glycines or serines have more conformational diversity than the others. CDR H3, despite having the same amino acid sequence, exhibits the largest conformational diversity. About half of the structures have CDR H3 conformations similar to that of the parent; the others diverge significantly. One conclusion is that the CDR H3 conformations are influenced by both their amino acid sequence and their structural environment determined by the heavy and light chain pairing. The stem regions of 14 of the variant pairs are in the 'kinked' conformation, and only 2 are in the extended conformation. The packing of the VH and VL domains is consistent with our knowledge of antibody structure, and the tilt angles between these domains cover a range of 11 degrees. Two of 16 structures showed particularly large variations in the tilt angles when compared with the other pairings. The structures and their analyses provide a rich foundation for future antibody modeling and engineering efforts.
Structural diversity in a human antibody germline library.,Teplyakov A, Obmolova G, Malia TJ, Luo J, Muzammil S, Sweet R, Almagro JC, Gilliland GL MAbs. 2016 May 21:1-19. PMID:27210805[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
References
- ↑ Teplyakov A, Obmolova G, Malia TJ, Luo J, Muzammil S, Sweet R, Almagro JC, Gilliland GL. Structural diversity in a human antibody germline library. MAbs. 2016 May 21:1-19. PMID:27210805 doi:http://dx.doi.org/10.1080/19420862.2016.1190060
|